Skip to main content

Advertisement

Log in

Mucopolysaccharidosis type I and craniosynostosis

  • Case Report - Pediatrics
  • Published:
Acta Neurochirurgica Aims and scope Submit manuscript

Abstract

Mucopolysaccharidosis type-I is caused by a deficiency of the lysosomal enzyme α-L-iduronidase, resulting in gradual deposition of glycosaminoglycans in multiple body organs, affecting physical appearance and system functioning. We present the first reported case associating MPS-I (Hurler-Scheie subtype) with craniosynostosis. A 2.5-year-old girl presented initially with macrocrania. On clinical and radiological examinations we noted a scaphocephaly with dysmorphic facial features of MPS confirmed later on. Intracranial hypertension was documented at fundoscopy (papilloedema) and ICP monitoring, and then surgically treated. This association of scaphocephaly and MPS-I highlights the importance of a meticulous physical examination performed by craniofacial, metabolic and ophthalmologic teams.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

References

  1. Brisman JL, Niimi Y, Berenstein A (2004) Sinus pericranii involving the torcular sinus in a patient with Hunter’s syndrome and trigonocephaly: case report and review of the literature. Neurosurgery 55:433

    Article  PubMed  Google Scholar 

  2. Cohen MM Jr (1991) Etiopathogenesis of craniosynostosis. Neurosurg Clin N Am 2:507–513

    PubMed  Google Scholar 

  3. Collins ML, Traboulsi EI, Maumenee IH (1990) Optic nerve head swelling and optic atrophy in the systemic mucopolysaccharidoses. Ophthalmology 97:1445–1449

    PubMed  CAS  Google Scholar 

  4. D’Aco K, Underhill L, Rangachari L, Arn P, Cox GF, Giugliani R, Okuyama T, Wijburg F, Kaplan P (2012) Diagnosis and treatment trends in mucopolysaccharidosis I: findings from the MPS I Registry. Eur J Pediatr 171:911–919

    Article  PubMed  Google Scholar 

  5. de Ru MH, Boelens JJ, Das AM, Jones SA, van der Lee JH, Mahlaoui N, Mengel E, Offringa M, O’Meara A, Parini R, Rovelli A, Sykora KW, Valayannopoulos V, Vellodi A, Wynn RF, Wijburg FA (2011) Enzyme replacement therapy and/or hematopoietic stem cell transplantation at diagnosis in patients with mucopolysaccharidosis type I: results of a European consensus procedure. Orphanet J Rare Dis 6:55

    Article  PubMed  Google Scholar 

  6. Ferrari S, Ponzin D, Ashworth JL, Fahnehjelm KT, Summers CG, Harmatz PR, Scarpa M (2010) Diagnosis and management of ophthalmological features in patients with mucopolysaccharidosis. Br J Ophthalmol 95:613–619

    Article  PubMed  Google Scholar 

  7. Lachman R, Martin KW, Castro S, Basto MA, Adams A, Teles EL (2010) Radiologic and neuroradiologic findings in the mucopolysaccharidoses. J Pediatr Rehabil Med 3:109–118

    PubMed  Google Scholar 

  8. Manara R, Priante E, Grimaldi M, Santoro L, Astarita L, Barone R, Concolino D, Di Rocco M, Donati MA, Fecarotta S, Ficcadenti A, Fiumara A, Furlan F, Giovannini I, Lilliu F, Mardari R, Polonara G, Procopio E, Rampazzo A, Rossi A, Sanna G, Parini R, Scarpa M (2011) Brain and spine MRI features of Hunter disease: frequency, natural evolution and response to therapy. J Inherit Metab Dis 34:763–780

    Article  PubMed  Google Scholar 

  9. Muenzer J, Wraith JE, Clarke LA (2009) Mucopolysaccharidosis I: management and treatment guidelines. Pediatrics 123:19–29

    Article  PubMed  Google Scholar 

  10. Osborn MJ, McElmurry RT, Lees CJ, DeFeo AP, Chen ZY, Kay MA, Naldini L, Freeman G, Tolar J, Blazar BR (2010) Minicircle DNA-based gene therapy coupled with immune modulation permits long-term expression of alpha-L-iduronidase in mice with mucopolysaccharidosis type I. Mol Ther 19:450–460

    Article  PubMed  Google Scholar 

  11. Schmidt H, Ullrich K, von Lengerke HJ, Kleine M, Bramswig J (1987) Radiological findings in patients with mucopolysaccharidosis I H/S (Hurler-Scheie syndrome). Pediatr Radiol 17:409–414

    Article  PubMed  CAS  Google Scholar 

  12. Summers CG, Ashworth JL (2011) Ocular manifestations as key features for diagnosing mucopolysaccharidoses. Rheumatology (Oxford) 50(Suppl 5):v34–40

    Article  Google Scholar 

  13. Wilson S, Hashamiyan S, Clarke L, Saftig P, Mort J, Dejica VM, Bromme D (2009) Glycosaminoglycan-mediated loss of cathepsin K collagenolytic activity in MPS I contributes to osteoclast and growth plate abnormalities. Am J Pathol 175:2053–2062

    Article  PubMed  CAS  Google Scholar 

  14. Wraith JE, Rogers JG, Danks DM (1987) The mucopolysaccharidoses. Aust Paediatr J 23:329–334

    PubMed  CAS  Google Scholar 

Download references

Conflicts of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jawad Ziyadeh.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ziyadeh, J., Le Merrer, M., Robert, M. et al. Mucopolysaccharidosis type I and craniosynostosis. Acta Neurochir 155, 1973–1976 (2013). https://doi.org/10.1007/s00701-013-1831-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00701-013-1831-9

Keywords

Navigation